APA
IONS icon

American Portfolios Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

American Portfolios Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$13.3K Hold
300
– – ﹤0.01% 2392
2022
Q2 		$11.1K Hold
300
– – ﹤0.01% 2521
2022
Q1 		$11.1K Hold
300
– – ﹤0.01% 2645
2021
Q4 		$9.13K Hold
300
– – ﹤0.01% 2655
2021
Q3 		$10.1K Hold
300
– – ﹤0.01% 2565
2021
Q2 		$12K Hold
300
– – ﹤0.01% 2437
2021
Q1 		$13.5K Hold
300
– – ﹤0.01% 2256
2020
Q4 		$17K Hold
300
– – ﹤0.01% 1896
2020
Q3 		$14.2K Hold
300
– – ﹤0.01% 1847
2020
Q2 		$17.7K Hold
300
– – ﹤0.01% 1690
2020
Q1 		$14.2K Hold
300
– – ﹤0.01% 1665
2019
Q4 		$18.1K Sell
300
-250
-45% -$14.9K ﹤0.01% 1763
2019
Q3 		$33K Hold
550
– – ﹤0.01% 1466
2019
Q2 		$35.3K Buy
550
+250
+83% +$17.7K ﹤0.01% 1420
2019
Q1 		$24.4K Sell
300
-25
-8% -$1.61K ﹤0.01% 1517
2018
Q4 		$17.6K Hold
325
– – ﹤0.01% 1425
2018
Q3 		$16.8K Hold
325
– – ﹤0.01% 1556
2018
Q2 		$13.5K Hold
325
– – ﹤0.01% 1609
2018
Q1 		$14.3K Sell
325
-100
-24% -$5.08K ﹤0.01% 1508
2017
Q4 		$21.4K Buy
+425
New +$23.3K ﹤0.01% 1293

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

American Portfolios Advisors's IONS Position: Q3 2022 in Review

American Portfolios Advisors held its Ionis Pharmaceuticals (IONS) position steady in Q3 2022 at 300 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

American Portfolios Advisors first reported a position in IONS in Q4 2017 and has held it in 20 quarters since. The position peaked at $35.3K in Q2 2019. 350 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

  • American Portfolios Advisors held 300 shares of Ionis Pharmaceuticals worth $13.3K as of Q3 2022.
  • American Portfolios Advisors left its Ionis Pharmaceuticals share count unchanged in Q3 2022.
  • Ionis Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2392 holding.
  • American Portfolios Advisors first reported a position in Ionis Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Ionis Pharmaceuticals position peaked at $35.3K in Q2 2019.
  • 350 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.